nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—NGF—hypertension	0.171	0.582	CbGaD
Clenbuterol—Pirbuterol—Nadolol—hypertension	0.0755	0.293	CrCrCtD
Clenbuterol—Bupranolol—Nadolol—hypertension	0.0433	0.168	CrCrCtD
Clenbuterol—Salbutamol—Nadolol—hypertension	0.0383	0.149	CrCrCtD
Clenbuterol—Bupranolol—Timolol—hypertension	0.0369	0.143	CrCrCtD
Clenbuterol—ADRB1—hypertension	0.0348	0.119	CbGaD
Clenbuterol—TNF—hypertension	0.0331	0.113	CbGaD
Clenbuterol—Bupranolol—Pindolol—hypertension	0.0321	0.125	CrCrCtD
Clenbuterol—Bupranolol—Penbutolol—hypertension	0.0313	0.122	CrCrCtD
Clenbuterol—ADRB2—hypertension	0.0293	0.1	CbGaD
Clenbuterol—ADRB3—Nadolol—hypertension	0.0252	0.0723	CbGbCtD
Clenbuterol—ADRB3—Labetalol—hypertension	0.0252	0.0723	CbGbCtD
Clenbuterol—CYP1A1—hypertension	0.0251	0.0858	CbGaD
Clenbuterol—ADRB3—Pindolol—hypertension	0.0214	0.0615	CbGbCtD
Clenbuterol—ADRB2—Esmolol—hypertension	0.0136	0.039	CbGbCtD
Clenbuterol—ADRB1—Esmolol—hypertension	0.0134	0.0384	CbGbCtD
Clenbuterol—ADRB3—Timolol—hypertension	0.0123	0.0353	CbGbCtD
Clenbuterol—NGF—superior cervical ganglion—hypertension	0.0119	0.415	CbGeAlD
Clenbuterol—ADRB3—Carvedilol—hypertension	0.0119	0.0342	CbGbCtD
Clenbuterol—ADRB3—Propranolol—hypertension	0.011	0.0315	CbGbCtD
Clenbuterol—ADRB2—Nadolol—hypertension	0.0103	0.0296	CbGbCtD
Clenbuterol—ADRB2—Labetalol—hypertension	0.0103	0.0296	CbGbCtD
Clenbuterol—ADRB2—Nebivolol—hypertension	0.0103	0.0296	CbGbCtD
Clenbuterol—ADRB1—Nadolol—hypertension	0.0102	0.0291	CbGbCtD
Clenbuterol—ADRB1—Nebivolol—hypertension	0.0102	0.0291	CbGbCtD
Clenbuterol—ADRB1—Labetalol—hypertension	0.0102	0.0291	CbGbCtD
Clenbuterol—ADRB2—Acebutolol—hypertension	0.00943	0.0271	CbGbCtD
Clenbuterol—ADRB1—Acebutolol—hypertension	0.00929	0.0266	CbGbCtD
Clenbuterol—ADRB2—Metoprolol—hypertension	0.00877	0.0252	CbGbCtD
Clenbuterol—ADRB2—Pindolol—hypertension	0.00877	0.0252	CbGbCtD
Clenbuterol—ADRB1—Metoprolol—hypertension	0.00863	0.0248	CbGbCtD
Clenbuterol—ADRB1—Pindolol—hypertension	0.00863	0.0248	CbGbCtD
Clenbuterol—ADRB2—Betaxolol—hypertension	0.00781	0.0224	CbGbCtD
Clenbuterol—ADRB1—Betaxolol—hypertension	0.00769	0.0221	CbGbCtD
Clenbuterol—ADRB2—Penbutolol—hypertension	0.00715	0.0205	CbGbCtD
Clenbuterol—ADRB1—Penbutolol—hypertension	0.00704	0.0202	CbGbCtD
Clenbuterol—NGF—sympathetic nervous system—hypertension	0.00652	0.226	CbGeAlD
Clenbuterol—ADRB2—Timolol—hypertension	0.00503	0.0144	CbGbCtD
Clenbuterol—ADRB1—Timolol—hypertension	0.00496	0.0142	CbGbCtD
Clenbuterol—ADRB2—Carvedilol—hypertension	0.00488	0.014	CbGbCtD
Clenbuterol—ADRB1—Carvedilol—hypertension	0.0048	0.0138	CbGbCtD
Clenbuterol—ADRB2—Propranolol—hypertension	0.00449	0.0129	CbGbCtD
Clenbuterol—ADRB1—Propranolol—hypertension	0.00442	0.0127	CbGbCtD
Clenbuterol—NGF—autonomic nervous system—hypertension	0.00438	0.152	CbGeAlD
Clenbuterol—CYP1A1—Prazosin—hypertension	0.00385	0.011	CbGbCtD
Clenbuterol—CYP1A1—Amlodipine—hypertension	0.00362	0.0104	CbGbCtD
Clenbuterol—CYP1A1—Nifedipine—hypertension	0.00337	0.00968	CbGbCtD
Clenbuterol—CYP1A1—Carvedilol—hypertension	0.00332	0.00953	CbGbCtD
Clenbuterol—CYP1A1—Propranolol—hypertension	0.00306	0.00877	CbGbCtD
Clenbuterol—CYP1A1—Clonidine—hypertension	0.00292	0.00837	CbGbCtD
Clenbuterol—CYP1A2—Triamterene—hypertension	0.00287	0.00823	CbGbCtD
Clenbuterol—CYP1A2—Guanabenz—hypertension	0.00287	0.00823	CbGbCtD
Clenbuterol—CYP1A2—Betaxolol—hypertension	0.00238	0.00682	CbGbCtD
Clenbuterol—CYP1A2—Nisoldipine—hypertension	0.00209	0.00601	CbGbCtD
Clenbuterol—CYP1A2—Irbesartan—hypertension	0.00165	0.00473	CbGbCtD
Clenbuterol—CYP1A2—Amlodipine—hypertension	0.00162	0.00464	CbGbCtD
Clenbuterol—CYP1A2—Nifedipine—hypertension	0.00151	0.00433	CbGbCtD
Clenbuterol—CYP1A2—Carvedilol—hypertension	0.00148	0.00426	CbGbCtD
Clenbuterol—CYP1A2—Propranolol—hypertension	0.00137	0.00392	CbGbCtD
Clenbuterol—CYP1A2—Clonidine—hypertension	0.0013	0.00374	CbGbCtD
Clenbuterol—CYP1A2—Losartan—hypertension	0.00106	0.00305	CbGbCtD
Clenbuterol—CYP1A2—Verapamil—hypertension	0.000937	0.00269	CbGbCtD
Clenbuterol—NGF—heart—hypertension	0.000915	0.0318	CbGeAlD
Clenbuterol—NGF—adrenal gland—hypertension	0.000683	0.0237	CbGeAlD
Clenbuterol—ADRB2—Treprostinil—Nadolol—hypertension	0.000641	1	CbGdCrCtD
Clenbuterol—CYP1A2—urine—hypertension	0.000608	0.0211	CbGeAlD
Clenbuterol—NGF—endocrine gland—hypertension	0.000592	0.0206	CbGeAlD
Clenbuterol—NGF—central nervous system—hypertension	0.000533	0.0185	CbGeAlD
Clenbuterol—ADRB1—cardiac ventricle—hypertension	0.000363	0.0126	CbGeAlD
Clenbuterol—ADRB1—myocardium—hypertension	0.000341	0.0119	CbGeAlD
Clenbuterol—Bambuterol—ADRB2—hypertension	0.000314	0.187	CrCbGaD
Clenbuterol—Pirbuterol—ADRB1—hypertension	0.000283	0.168	CrCbGaD
Clenbuterol—ADRB1—heart—hypertension	0.000238	0.00827	CbGeAlD
Clenbuterol—Pirbuterol—ADRB2—hypertension	0.000238	0.142	CrCbGaD
Clenbuterol—CYP1A1—cardiac ventricle—hypertension	0.000234	0.00813	CbGeAlD
Clenbuterol—ADRB1—cardiovascular system—hypertension	0.000225	0.00781	CbGeAlD
Clenbuterol—ADRB1—cardiac atrium—hypertension	0.000204	0.00708	CbGeAlD
Clenbuterol—Terbutaline—ADRB2—hypertension	0.000194	0.115	CrCbGaD
Clenbuterol—Bupranolol—ADRB1—hypertension	0.000182	0.109	CrCbGaD
Clenbuterol—Salbutamol—ADRB1—hypertension	0.000171	0.102	CrCbGaD
Clenbuterol—ADRB1—endocrine gland—hypertension	0.000154	0.00536	CbGeAlD
Clenbuterol—CYP1A1—heart—hypertension	0.000154	0.00534	CbGeAlD
Clenbuterol—Bupranolol—ADRB2—hypertension	0.000153	0.0913	CrCbGaD
Clenbuterol—Salbutamol—ADRB2—hypertension	0.000144	0.0858	CrCbGaD
Clenbuterol—CYP1A1—kidney—hypertension	0.000142	0.00493	CbGeAlD
Clenbuterol—ADRB1—central nervous system—hypertension	0.000139	0.00483	CbGeAlD
Clenbuterol—CYP1A1—cardiac atrium—hypertension	0.000131	0.00456	CbGeAlD
Clenbuterol—CYP1A2—endocrine gland—hypertension	0.000101	0.0035	CbGeAlD
Clenbuterol—CYP1A1—endocrine gland—hypertension	9.94e-05	0.00345	CbGeAlD
Clenbuterol—CYP1A1—central nervous system—hypertension	8.96e-05	0.00311	CbGeAlD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL8—hypertension	1.33e-06	1.89e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EDN1—hypertension	1.32e-06	1.88e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—hypertension	1.31e-06	1.87e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL5—hypertension	1.31e-06	1.87e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LPL—hypertension	1.31e-06	1.86e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RELA—hypertension	1.3e-06	1.86e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—H2AFX—hypertension	1.3e-06	1.85e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GCG—hypertension	1.3e-06	1.85e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SLC2A4—hypertension	1.3e-06	1.85e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RPS6KB1—hypertension	1.29e-06	1.85e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PDGFRB—hypertension	1.29e-06	1.85e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—hypertension	1.29e-06	1.84e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—LRP2—hypertension	1.28e-06	1.83e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP2C18—hypertension	1.28e-06	1.83e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ADCY5—hypertension	1.28e-06	1.83e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LPL—hypertension	1.28e-06	1.82e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MTOR—hypertension	1.28e-06	1.82e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PRKCG—hypertension	1.27e-06	1.81e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—H2AFX—hypertension	1.27e-06	1.81e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PDGFRB—hypertension	1.27e-06	1.81e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RPS6KB1—hypertension	1.27e-06	1.81e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ITGB3—hypertension	1.26e-06	1.8e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PRKCA—hypertension	1.26e-06	1.8e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GOT1—hypertension	1.25e-06	1.79e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—YWHAZ—hypertension	1.25e-06	1.79e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ADCY5—hypertension	1.25e-06	1.79e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—hypertension	1.25e-06	1.78e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PRKCG—hypertension	1.24e-06	1.77e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SPP1—hypertension	1.24e-06	1.77e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NGF—hypertension	1.24e-06	1.77e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—HSPG2—hypertension	1.23e-06	1.76e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ITGB3—hypertension	1.23e-06	1.76e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PRKCA—hypertension	1.23e-06	1.76e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL8—hypertension	1.23e-06	1.76e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AKT1—hypertension	1.23e-06	1.75e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL8—hypertension	1.23e-06	1.75e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—YWHAZ—hypertension	1.22e-06	1.75e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—hypertension	1.22e-06	1.74e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—STK11—hypertension	1.22e-06	1.74e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP19A1—hypertension	1.22e-06	1.74e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SPP1—hypertension	1.21e-06	1.73e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NGF—hypertension	1.21e-06	1.73e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—hypertension	1.21e-06	1.73e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—hypertension	1.21e-06	1.72e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL8—hypertension	1.2e-06	1.72e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR5—hypertension	1.2e-06	1.72e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PRKCD—hypertension	1.2e-06	1.72e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALOX5—hypertension	1.19e-06	1.7e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GLP1R—hypertension	1.19e-06	1.7e-05	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AKT1—hypertension	1.18e-06	1.69e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR2A—hypertension	1.18e-06	1.68e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PRKCD—hypertension	1.18e-06	1.68e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR5—hypertension	1.18e-06	1.68e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—C3—hypertension	1.18e-06	1.68e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—hypertension	1.17e-06	1.66e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR2A—hypertension	1.15e-06	1.64e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—C3—hypertension	1.15e-06	1.64e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PDGFB—hypertension	1.14e-06	1.63e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hypertension	1.14e-06	1.63e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGFR1—hypertension	1.14e-06	1.63e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—COMT—hypertension	1.13e-06	1.62e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HIF1A—hypertension	1.12e-06	1.6e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PDGFB—hypertension	1.12e-06	1.6e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AGT—hypertension	1.12e-06	1.59e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GNB3—hypertension	1.12e-06	1.59e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARGC1A—hypertension	1.12e-06	1.59e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGFR1—hypertension	1.11e-06	1.59e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—HMOX1—hypertension	1.11e-06	1.59e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—hypertension	1.11e-06	1.58e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN1A—hypertension	1.1e-06	1.58e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTEN—hypertension	1.1e-06	1.57e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CALM1—hypertension	1.1e-06	1.57e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HIF1A—hypertension	1.1e-06	1.57e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CAT—hypertension	1.1e-06	1.57e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOE—hypertension	1.09e-06	1.56e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LEP—hypertension	1.09e-06	1.56e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AGT—hypertension	1.09e-06	1.56e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hypertension	1.09e-06	1.56e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALDH2—hypertension	1.09e-06	1.56e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GNAS—hypertension	1.09e-06	1.55e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CAV1—hypertension	1.08e-06	1.55e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOA1—hypertension	1.08e-06	1.54e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAPK8—hypertension	1.08e-06	1.54e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AKT1—hypertension	1.08e-06	1.53e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CALM1—hypertension	1.07e-06	1.53e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KDR—hypertension	1.07e-06	1.53e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LEP—hypertension	1.07e-06	1.53e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOE—hypertension	1.07e-06	1.53e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOB—hypertension	1.06e-06	1.52e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—hypertension	1.06e-06	1.52e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—HBA1—hypertension	1.06e-06	1.52e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CAV1—hypertension	1.06e-06	1.51e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOA1—hypertension	1.06e-06	1.51e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP11A1—hypertension	1.06e-06	1.51e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EP300—hypertension	1.05e-06	1.5e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KDR—hypertension	1.05e-06	1.5e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypertension	1.05e-06	1.5e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTT1—hypertension	1.04e-06	1.48e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC9A1—hypertension	1.04e-06	1.48e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTM1—hypertension	1.04e-06	1.48e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—F2—hypertension	1.03e-06	1.47e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FN1—hypertension	1.03e-06	1.47e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PRKCB—hypertension	1.03e-06	1.47e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GCLC—hypertension	1.03e-06	1.46e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CETP—hypertension	1.03e-06	1.46e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SRC—hypertension	1.02e-06	1.46e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—LPL—hypertension	1.02e-06	1.45e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOTCH1—hypertension	1.01e-06	1.44e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PRKCB—hypertension	1.01e-06	1.44e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—F2—hypertension	1.01e-06	1.44e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FN1—hypertension	1.01e-06	1.44e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VEGFA—hypertension	9.96e-07	1.42e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ADCY5—hypertension	9.95e-07	1.42e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GPX1—hypertension	9.92e-07	1.42e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOTCH1—hypertension	9.89e-07	1.41e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PRKCA—hypertension	9.82e-07	1.4e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP17A1—hypertension	9.82e-07	1.4e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ENO1—hypertension	9.72e-07	1.39e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS1—hypertension	9.72e-07	1.39e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CD36—hypertension	9.66e-07	1.38e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hypertension	9.56e-07	1.36e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—POMC—hypertension	9.41e-07	1.34e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—INS—hypertension	9.35e-07	1.34e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CTGF—hypertension	9.35e-07	1.33e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—HMGCR—hypertension	9.27e-07	1.32e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GOT2—hypertension	9.27e-07	1.32e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL2—hypertension	9.2e-07	1.31e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—POMC—hypertension	9.2e-07	1.31e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MYC—hypertension	9.16e-07	1.31e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MTHFR—hypertension	9.16e-07	1.31e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—INS—hypertension	9.15e-07	1.31e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	9.14e-07	1.3e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFB1—hypertension	9.14e-07	1.3e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ADRA2A—hypertension	9.07e-07	1.29e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF1—hypertension	9.05e-07	1.29e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AKT2—hypertension	9.04e-07	1.29e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EGFR—hypertension	9e-07	1.28e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL2—hypertension	9e-07	1.28e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARA—hypertension	8.98e-07	1.28e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGFR—hypertension	8.96e-07	1.28e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF1—hypertension	8.85e-07	1.26e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AKT2—hypertension	8.84e-07	1.26e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EGFR—hypertension	8.81e-07	1.26e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AGT—hypertension	8.7e-07	1.24e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SERPINE1—hypertension	8.59e-07	1.23e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CALM1—hypertension	8.55e-07	1.22e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOE—hypertension	8.52e-07	1.22e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TH—hypertension	8.49e-07	1.21e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CALM2—hypertension	8.46e-07	1.21e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CAV1—hypertension	8.44e-07	1.21e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOA1—hypertension	8.43e-07	1.2e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SERPINE1—hypertension	8.41e-07	1.2e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—hypertension	8.36e-07	1.19e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGF2—hypertension	8.32e-07	1.19e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RHOA—hypertension	8.29e-07	1.18e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC2A4—hypertension	8.26e-07	1.18e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GCG—hypertension	8.26e-07	1.18e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3R1—hypertension	8.2e-07	1.17e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOS3—hypertension	8.2e-07	1.17e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGF2—hypertension	8.14e-07	1.16e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RHOA—hypertension	8.11e-07	1.16e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOS3—hypertension	8.02e-07	1.15e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3R1—hypertension	8.02e-07	1.15e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GOT1—hypertension	8e-07	1.14e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—STK11—hypertension	7.77e-07	1.11e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP19A1—hypertension	7.77e-07	1.11e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RELA—hypertension	7.72e-07	1.1e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MTOR—hypertension	7.57e-07	1.08e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RELA—hypertension	7.55e-07	1.08e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—hypertension	7.52e-07	1.07e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARG—hypertension	7.42e-07	1.06e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MTOR—hypertension	7.41e-07	1.06e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—POMC—hypertension	7.32e-07	1.04e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hypertension	7.29e-07	1.04e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—INS—hypertension	7.28e-07	1.04e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL8—hypertension	7.28e-07	1.04e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—COMT—hypertension	7.22e-07	1.03e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GNB3—hypertension	7.12e-07	1.02e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARGC1A—hypertension	7.12e-07	1.02e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL8—hypertension	7.12e-07	1.02e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—HMOX1—hypertension	7.09e-07	1.01e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AKT1—hypertension	7.03e-07	1e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CAT—hypertension	6.99e-07	9.98e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hypertension	6.95e-07	9.92e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GNAS—hypertension	6.93e-07	9.9e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—hypertension	6.92e-07	9.88e-06	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—hypertension	6.89e-07	9.83e-06	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AKT1—hypertension	6.88e-07	9.81e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOB—hypertension	6.79e-07	9.69e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—hypertension	6.77e-07	9.66e-06	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALB—hypertension	6.68e-07	9.53e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTM1—hypertension	6.61e-07	9.43e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—hypertension	6.58e-07	9.39e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN1A—hypertension	6.56e-07	9.36e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTEN—hypertension	6.54e-07	9.34e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—LPL—hypertension	6.48e-07	9.25e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—hypertension	6.44e-07	9.19e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN1A—hypertension	6.42e-07	9.16e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAPK8—hypertension	6.4e-07	9.14e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTEN—hypertension	6.4e-07	9.13e-06	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NOS3—hypertension	6.39e-07	9.11e-06	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3R1—hypertension	6.39e-07	9.11e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AKT1—hypertension	6.38e-07	9.11e-06	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AKT1—hypertension	6.35e-07	9.07e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ADCY5—hypertension	6.35e-07	9.06e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GPX1—hypertension	6.33e-07	9.03e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP1A1—hypertension	6.26e-07	8.94e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PRKCA—hypertension	6.26e-07	8.94e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAPK8—hypertension	6.26e-07	8.94e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AKT1—hypertension	6.24e-07	8.91e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EP300—hypertension	6.24e-07	8.91e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CD36—hypertension	6.16e-07	8.79e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EP300—hypertension	6.1e-07	8.71e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SRC—hypertension	6.07e-07	8.66e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SRC—hypertension	5.94e-07	8.47e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VEGFA—hypertension	5.91e-07	8.43e-06	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—hypertension	5.84e-07	8.34e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MTHFR—hypertension	5.84e-07	8.33e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VEGFA—hypertension	5.78e-07	8.25e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARA—hypertension	5.73e-07	8.17e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AGT—hypertension	5.55e-07	7.92e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CALM1—hypertension	5.45e-07	7.78e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MYC—hypertension	5.44e-07	7.76e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOE—hypertension	5.43e-07	7.76e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFB1—hypertension	5.42e-07	7.74e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CAV1—hypertension	5.38e-07	7.68e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOA1—hypertension	5.37e-07	7.67e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MYC—hypertension	5.32e-07	7.59e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGFR—hypertension	5.32e-07	7.59e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFB1—hypertension	5.31e-07	7.57e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGFR—hypertension	5.2e-07	7.43e-06	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTEN—hypertension	5.09e-07	7.27e-06	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—EP300—hypertension	4.86e-07	6.93e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARG—hypertension	4.73e-07	6.76e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—POMC—hypertension	4.67e-07	6.66e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—INS—hypertension	4.64e-07	6.63e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—hypertension	4.47e-07	6.37e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—hypertension	4.37e-07	6.23e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALB—hypertension	4.26e-07	6.07e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—hypertension	4.09e-07	5.83e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NOS3—hypertension	4.07e-07	5.81e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3R1—hypertension	4.07e-07	5.81e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—hypertension	4e-07	5.71e-06	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AKT1—hypertension	3.77e-07	5.38e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—hypertension	3.72e-07	5.31e-06	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AKT1—hypertension	3.69e-07	5.26e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTEN—hypertension	3.25e-07	4.63e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—EP300—hypertension	3.1e-07	4.42e-06	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AKT1—hypertension	2.94e-07	4.19e-06	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AKT1—hypertension	1.87e-07	2.67e-06	CbGpPWpGaD
